202827-81-4

Basic information

• Product Name: C₁₆H₁₅BrN₂O
• Synonyms: C₁₆H₁₅BrN₂O
• CAS NO: 202827-81-4
• Molecular Weight: 331.212
• Mol File: 202827-81-4.mol

Chemical Properties

• CAS DataBase Reference: C₁₆H₁₅BrN₂O(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₆H₁₅BrN₂O(202827-81-4)
• EPA Substance Registry System: C₁₆H₁₅BrN₂O(202827-81-4)

Safety Data

• Hazardous Substances Data: 202827-81-4(Hazardous Substances Data)

Upstream product

• 100-06-1 1-(4-methoxyphenyl)ethanone 
• 1122-91-4 4-bromo-benzaldehyde 
• 92873-00-2 4-bromo-4'-methoxychalcone 

Downstream Products

• 1381883-41-5 (5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)(6-methylpyridin-3-yl)methanone 
• 1381883-37-9 (5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)(5-bromopyridin-3-yl)methanone 
• 1381883-38-0 (5-(4-bromophenyl)-3-(4-methylphenylether)-4,5-dihydro-1H-pyrazol-1-yl)(6-chloro-3-pyridyl)methanone 
• 1381883-40-4 (5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)(2-chloropyridin-3-yl)methanone 
• 1381883-39-1 (5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)(2-chloro-6-methylpyridin-3-yl)methanone 
• 1402058-42-7 (5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)(2-hydroxy-5-methoxyphenyl)methanone 
• 1402058-40-5 (5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)(2-hydroxy-5-iodophenyl)methanone 
• 1402058-38-1 (5-bromo-2-hydroxyphenyl)(5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)methanone 
• 1402058-36-9 (5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl) (4-chloro-2-hydroxyphenyl)methanone 
• 1402058-34-7 (5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl) (5-chloro-2-hydroxyphenyl)methanone 

Relevant articles and documents

Discovery and Pharmacophore Studies of Novel Pyrazole-Based Anti-Melanoma Agents

Due to the rising incidence and lack of effective treatments, malignant melanoma is the most dangerous form of skin cancer, so that new treatment strategies are urgently needed. Several recent developments indicate that the V600E mutant BRAF (BRAFV60

Synthesis, biological evaluation and 3D-QSAR studies of novel 4,5-dihydro-1H-pyrazole niacinamide derivatives as BRAF inhibitors

A series of novel 4,5-dihydropyrazole derivatives containing niacinamide moiety as potential V600E mutant BRAF kinase (BRAFV600E) inhibitors were designed and synthesized. Results of the bioassays against BRAF V600E and WM266.4 human

Identification of novel 3,5-diarylpyrazoline derivatives containing salicylamide moiety as potential anti-melanoma agents

There is an accumulating body of experimental evidences validating oncogenic BRAFV600E as a therapeutic target and offering opportunities for anti-melanoma drug development. Encouraged by the positive results of pyrazole derivatives as BRAFsup